Organic AIE Nanoradiosensitizer Potentiates X‐Ray Triggered Continuous Reactive Oxygen Species Generation for Potent Cancer Radioimmunotherapy
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Organic radiosensitizers (ORSs), with structural versatility, hold promise for sensitizing radiotherapy (RT) by interacting with X‐ray photons to generate reactive oxygen species (ROS). They often consist of low‐Z elements that have inherently low X‐ray deposition capability. However, current ORSs suffer from short circulation half‐lives and low tumor retention, contradicting their requirements for sustained ROS generation upon RT in tumor sites. Herein, a glutathione‐responsive system is prepared, loaded with aggregation‐induced emission molecules (TPEPy‐I) and Ferriprotoporphyrin IX chloride (Hemin), to act as an ORS (named THN) for X‐ray triggered sustained ROS generation for efficient antitumor immunotherapy. In detail, THN effectively deposited X‐ray photons, which interact with water molecules to generate abundant ROS under external radiation. Subsequently, THN‐mediated radiosensitization stimulated tumor cells to produce hydrogen peroxide (H 2 O 2 ) by upregulating NOX4 protein, promoting the chemodynamic process of Hemin reacting with H 2 O 2 to continuously produce hydroxyl radicals. The double‐promoting ROS generation of THN induced massive immunogenic cancer cell death and polarized M2 macrophages into the M1 phenotype for enhanced antitumor immunotherapy. Experiments revealed that THN‐sensitized RT inhibited tumor recurrence and increased memory T‐cell proportion for long‐term antitumor immunity. The developed ORS has great clinical potential as both a radiosensitizer and a post‐RT immunomodulatory agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These platforms typically incorporate catalytic components, including manganese-, iron-, or copper-containing materials, that exploit endogenous hydrogen peroxide within the tumor microenvironment to generate highly reactive hydroxyl radicals through Fenton or Fenton-like reactions [87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with these vulnerabilities, many of the more advanced nanoplatforms identified in this review—including systems targeting sustained ROS amplification, redox disruption, ferroptosis-associated pathways, and immune activation—were preferentially evaluated in TNBC models [23,26,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In catalytic and chemodynamic systems, sustained intracellular ROS production can maintain oxidative stress beyond the initial irradiation event, promoting persistent DNA damage, delaying repair processes, and increasing the probability of irreversible reproductive cell death [17,31,68,77,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These observations support the emerging view that durable disruption of tumor redox homeostasis may be more therapeutically relevant than transient ROS amplification alone, particularly in tumors with high antioxidant capacity and adaptive stress-response pathways [31,68,77,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition to physical dose amplification, several contemporary nanoplatforms incorporate catalytic or chemodynamic mechanisms capable of sustaining oxidative stress through endogenous hydrogen peroxide conversion and glutathione depletion [31,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geant4 developments and applications
Allison, J., Amako, K., Apostolakis, J., Araujo, H., Arce Dubois, P., Asai, M., Barrand, G., Capra, R., Chauvie, S., Chytracek, R., et al. (2006) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.2006.869826 · Cited by 6,946
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
NIR‐II AIEgens: A Win–Win Integration towards Bioapplications
Xu, W., Wang, D., & Tang, B. Z. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202005899 · Cited by 457
Self-citationSong, G., Liang, C., Gong, H., Li, M., Zheng, X., Cheng, L., Yang, K., Jiang, X., & Liu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503006 · Cited by 353
Experimental benchmarks of the Monte Carlo code penelope
Sempau, J., Fernández-Varea, J. M., Acosta, E., & Salvat, F. (2003) · Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms · doi:10.1016/s0168-583x(03)00453-1 · Cited by 347
Ning, S., Lyu, M., Zhu, D., Lam, J. W. Y., Huang, Q., Zhang, T., & Tang, B. Z. (2023) · ACS Nano · doi:10.1021/acsnano.3c00326 · Cited by 293
Self-citationRecent applications of immunomodulatory biomaterials for disease immunotherapy
Dai, H., Fan, Q., & Wang, C. (2022) · Exploration · doi:10.1002/exp.20210157 · Cited by 268
Wang, K., Li, Y., Wang, X., Zhang, Z., Cao, L., Fan, X., Wan, B., Liu, F., Zhang, X., He, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38601-7 · Cited by 253
Self-citationZhu, D., Chen, H., Huang, C., Li, G., Wang, X., Jiang, W., & Fan, K. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202110268 · Cited by 205
Bian, H., Ma, D., Zhang, X., Xin, K., Yang, Y., Peng, X., & Xiao, Y. (2021) · Small · doi:10.1002/smll.202100398 · Cited by 201
Self-citation
Cited by
Suo, M., Yang, D., Yang, M., Wang, J., Zhang, D., Zhu, D., Xu, Q., & Song, Y. (2025) · Advanced Science · doi:10.1002/advs.202518037 · Cited by 34
Self-citationXu, S., Huang, B., Lin, H., Li, J., Lu, Z., Zhang, Q., Li, J., Yang, S., Lan, S., Yang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202516783 · Cited by 33
Wang, W., Liu, Y., Xu, J., Deng, Y., Chen, W., Lin, Y., Tang, B. Z., & Zhang, M. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217553 · Cited by 21
Self-citationThe Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission
Lin, Z., He, T., Kang, M., Xie, W., Wang, D., & Tang, B. Z. (2025) · Aggregate · doi:10.1002/agt2.70189 · Cited by 17
“Upon internalization by 4T1 cells, THN generates ROS under X-ray irradiation to trigger ICD, polarizes M2-type TAM to M1-type TAM, and creates an immune-activated TME in animal model [152].”
Self-citationWang, J., Shu, Z., Chen, J., Bei, J., Wu, Y.-C., Chen, T., Wang, Y., Du, Y., & Yao, Y. S. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05397 · Cited by 9
Li, S., Zeng, Q., Zhu, S., Wan, L., Du, J., Xiang, D., Zheng, P., Zhu, W., Nie, C., & Pan, Q. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174085 · Cited by 7
Hu, Z., Li, H., Gan, K., Li, Y., Jiang, Y. X., Zhang, K., Li, Z., Zhou, Y., Lü, T., Xu, C., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03879-w · Cited by 8
Kumar, S., Rathaur, S., Maity, D., Varshney, P., & Gayen, J. R. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2637591 · Cited by 17
Molecular response of photodynamic therapy in oncology: A comprehensive review
Nkune, N. W., & Abrahamse, H. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119584 · Cited by 9
Adaptive ROS Regulating Nanomedicine for Tumor Catalytic and Immunotherapy beyond Oxidative Overload
Zhu, H., He, H., Chen, Z., Zhu, J., Sun, J., & Zhang, J. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00083 · Cited by 5
H-ferritin engineered nanoplatform reprograms metabolism and immunity for glioblastoma immunotherapy
Zuo, J., Huang, Y., Tian, H., Qin, S., Yan, Y., Yan, H., Jiang, Y., Li, L., Wang, S., Jia, Y., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114613 · Cited by 4
Nanoengineering‐Based Strategies for Enhancing Dynamic Therapy
Tian, C., Wang, Y., Chen, Z., Wu, Q., & Meng, X. (2026) · Small · doi:10.1002/smll.202511567 · Cited by 4
Zhao, Y., Fu, J., Zhao, P., Jiang, Y., Wang, Y., Zhang, Y., Li, Z., Zhao, Y., Li, N., Lang, B., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03147-2 · Cited by 6
“These cutting-edge nanomedicine strategies highlight the immense therapeutic potential of coupling ROS/ferroptosis induction with precise macrophage repolarization [170].”
Bao, X., Zheng, Z., Li, M., Wang, X., Zhao, Q., Wang, H., Xin, Y., & Jiang, X. M. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217234 · Cited by 4
Xiao, Z., Zhou, X., Zhang, L., Zhao, D., Cai, W., & Wang, J. (2025) · Biomedical Microdevices · doi:10.1007/s10544-025-00780-z · Cited by 3
“In recent years, owing to the complexity, diversity, and heterogeneity of tumors, radiotherapy (RT) has often been used to treat tumors in clinics(Xu et al. 2025; Giordano et al. 2024).”
Zhang, H., Deng, Y., Lu, Y., Wang, M., Qiao, K., Yang, Z., Ning, S., & Liu, T. (2025) · Advanced Science · doi:10.1002/advs.202515097 · Cited by 4
Self-citationDu, Y., Kong, H., Zheng, H., Lin, X., LÜ, T., Zhao, Y., Wang, K. J., Zhou, J., Huang, R., Zhang, S., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176132 · Cited by 3
Yao, X., Ruan, Y., Rao, T., Lin, F., & Zhang, W. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152036 · Cited by 2
Prussian blue and its analogue nanoparticles: Appealing nanotheranostics for malignant tumor
Cui, X., Niu, Y., Yang, Y., Zhao, F., Yin, Y., Tong, L., Gao, J., Shi, W., Shen, X., Zeng, Q., et al. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218005 · Cited by 2
Liu, Z., Liu, X., Wei, J., Gao, S., Liu, Y., Wang, B., Yang, X., Zhang, J., & Jin, Y. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116024 · Cited by 2
Self-citationPark, G., Kim, S., Kim, D., Hwang, I., & Ryu, J. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504629 · Cited by 1
Zang, Q., Chen, W., Shen, Y., Wang, Z.-Y., Li, K., Zhao, X., Sang, Y., Chen, X. S., & Zang, S. (2026) · Advanced Science · doi:10.1002/advs.202517021 · Cited by 1
Self-citationLi, X., Zhou, Q., Duan, S., Zhang, L., Li, Z., Chen, S., Yuan, Y., Liu, Y., Li, Y., Cai, X., et al. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s589815 · Cited by 2
“12 Recent advances in nanotechnology have greatly expanded the potential of SDT. 11 Among various nanomaterials, metal-organic frameworks (MOFs) have emerged as versatile platforms for biomedical applications.”
Teng, J., Zhang, X., Shen, C., Wang, L., Hu, J., Li, Z., Liu, Y., Liu, J., Wei, S., & Wang, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s597376 · Cited by 4
“113”
Self-citationGao, F., Wu, Y., Chen, X., Chen, J., Liu, Y., 黄爱霞, Fu, Y., Chen, D., Lin, F., & Zhou, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s600409 · Cited by 1
Qin, X., Zhang, P., Deng, L., Wang, L., Ma, Y., Ma, P., 肖江卫, & Zhao, M. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.178601 · Cited by 1
ROS as a powerful instrument for the advanced cancer prevention and management: Facts and outlook
Tang, Q., Cui, L., Du, W., Ruan, Y., Yang, L., Fu, C., Gui, J., Liu, Q., Chen, Y., Qiao, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.002 · Cited by 1
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
Zhang, Q., Xu, Z., Xie, Y., Bao, Y., Shan, X., Sun, T., Shen, L., Wang, Z., Xu, H. L., Redshaw, C., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.171925
Cao, C., Pan, X., Jiao, Y., Chen, W., Cao, Y., Hao, H., Cui, X., Gao, D., Wang, Y., Cui, S., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c16641
Self-citationYao, J., Yao, J., Xin, Y., Liu, X., Gao, Y., Zheng, X., Hua, X., Hui, J., & Fan, D. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202531433
Recent Advances in Antitumor Nanomedicine Based on Covalent Organic Frameworks
Xu, F., Ruoyu, W., Cheng, Z., Zhang, Z., & Tian, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s378082
Meng, X., Zhang, Y., Cui, Y., Zhang, Y., Guo, H., Yi, P., Xu, F., Xiao, J., Zhang, G., & Tian, G. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115824
Qin, R., Li, Y., Qiu, T., Wang, R., Li, Y., Shi, S. Q., Liu, Y., Zhou, D., Fan, J., Zeng, X., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124332
Nanobioconjugate Trispecific Antibody Augments Antitumor Immunity of Triple Negative Breast Cancer
Chang, Q., & Liu, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s610232
“55,56 59 However, most of these therapy strategies still have many imperfections.”
Wang, K., Liu, X., Jia, Y., Pan, W., & Li, N. (2026) · Chemical Communications · doi:10.1039/d6cc03471c
Yang, R., Jiang, H., Zhang, D., Sun, G., Li, M., Jiang, B., Yang, B., Zheng, B., Zhao, Y., Han, X., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.06.050
Water/Alcohol-soluble Organic Luminophores: A Review
Chen, T., Wei, X. E., Liu, W., & Zhang, X. (2026) · Chinese Journal of Polymer Science · doi:10.1007/s10118-026-3650-5
Self-citationWang, J., Xie, T., Jiang, H., Shan, Y., Juengpanich, S., Li, S., Topatana, W., Liu, Y., Wan, H., Qian, Y., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04733-3 · Cited by 1
Gahbiche, O., Ajjel, R., Chiba, E., Marzouki, R., & Mezni, A. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115999
Yang, L., Raza, F., Song, J., Xi, X., Yang, S., Xiao, H., Jiang, L., Chen, W., Zhong, J., Qiu, M., et al. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116023
Self-citationChen, D., Chang, P., Tian, K., Yang, X., Wang, T., Cui, L., Zhao, S., Li, K., Chen, D., Lu, H., et al. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01991-5
Xu, Y., Zhao, T., Li, Z., Chen, J., Li, X., Zhou, X., Khouchani, M., Abdelmajid, T., Jiang, Z., Zhao, L., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04869-2
“In addition, DCFH-DA fluorescent probe was utilized to observe the ROS generation in cells [36].”
Wang, W., Niu, Z., He, L., Liu, Y., Shen, Z., Zhao, L., Yin, X., & Zeng, L. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2026.141286
Chen, Y., Wang, X., Li, R., Zhang, M., Song, X., Han, X., & Dong, X. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c10351
Self-citationLiu, S., Liu, Y., Fan, Q., Wen, K., Zhang, J., Yang, Y., Yang, S., Yu, G., & Dong, Z. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124532
Zhang, W., Wang, B., Peng, S., Zhang, L., Huang, R., Gao, F., Huang, W., Liu, W., Nie, X., You, Y., et al. (2026) · Advanced Materials · doi:10.1002/adma.74384
“In the same tumor sections, CRT exposure and reduced HMGB1 retention indicated ICD-associated DAMP signaling after Ni/LDH@M + US treatment (Figure 6b,c ) [ 43, 44 ].”
Zhou, H., Yu, C., Xu, G., Liu, L., Liang, Y., Liang, Y., Ding, H., Zhang, L., Yang, D., & Wang, C. (2026) · Advanced Science · doi:10.1002/advs.77120
“Cells release DAMPs to activate DCs and promote antigen presentation, such as cell-surface-exposed calreticulin (CRT), high-mobility group protein B1 (HMGB1), and adenosine triphosphate (ATP) exposed on the cell surface [ 37, 38 ].”
Kadam, Y., Desai, S. A., Parkhe, V., & Patel, V. P. (2026) · Biomaterials and Living Medicine for Pharmaceutics · doi:10.1016/j.bioliv.2026.100008
Zhao, Y., Ren, L., Hu, J., Yan, L., Zhou, Y., Geng, B., & Zhang, X. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181224
Self-citationWang, W., Deng, Y., Tang, Z., Zhang, Q., Xu, Y., Lin, Y., Tang, B. Z., & Zhang, M. (2026) · Advanced Functional Materials · doi:10.1002/adfm.78039
Self-citationJiang, C., Yang, Z., Guo, R., Suo, M., Wang, G., Chen, D., Su, L., Wang, F., Ning, S., Fan, K., et al. (2026) · Advanced Science · doi:10.1002/advs.77309
“Unlike inorganic nanozymes, which are limited by their rigid structure, poor modifiability and unsatisfactory biosafety, organic nanozymes possess distinct merits, including favorable biocompatibility, excellent biodegradability and flexible molecular engineering capability [ 22, 23 ].”
Self-citationChen, L., Jiang, S.-S., Wang, J., & Cao, X.-J. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2026.128699
Self-assembly of paclitaxel and cyclosporine A to overcome tumor drug resistance
Qu, X., Xuan, J., Fu, D., Zhao, J., Xi, T., & Sun, L. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116183
Pan, Y., Cai, W., Suo, M., Meng, X., Ye, S., Tan, Y., Wei, X., Yang, M., Qi, P., Yu, Z., et al. (2026) · Exploration · doi:10.1002/exp2.70224
Self-citationLi, R., Sun, Y., Xiao, M., Tang, Y., Wu, J., Yan, D., Luo, Q., Lin, Y., Han, R., Kang, M., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c00356
Self-citationChen, B., Tao, X., Wang, Y., Wang, X., Wu, Y., & Chen, W. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71740
Self-citationHDACs-targeting photosensitizer-based local-therapy augmenting photoimmunotherapy in bladder cancer
Chen, Y., Yu, Y., Xu, W., Fan, L., Chen, Q., Federico, S., Wang, M., Cheng, T., Shi, L., Han, B., et al. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.101004
A living hydrogel platform for wireless light-controlled microbial therapy in the stomach
Li, H., Zhang, C., Yao, H., Wang, Y., Jiang, Y., Bai, G., Li, L., Feng, Z., Liu, D., & Wang, H. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2026.141720
Yu, Y., Zhao, J., Li, J., Li, J., Xu, X., Liang, H., Yuan, C., Dong, S., Gu, M., & Li, Z. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218616
Wang, H., Wang, C., Ma, S., Feng, X., Jiao, F., Xue, P., Fei, F., Xiao, J., Long, L., Wu, X., et al. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116267
Chen, X., Bai, Y., Ning, Y., Hou, X., Zhang, J., Liu, Y., Zhang, Z., Liu, J., & Huang, F. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.6258337
Chen, X., Bai, Y., Ning, Y., Hou, X., Zhang, J., Liu, Y., Zhang, Z., Liu, J., & Huang, F. (2026) · Angewandte Chemie · doi:10.1002/ange.6258337
Li, Q., Zhao, G., Shen, H., Huang, Z. H., Chen, T., Shi, M., Zhang, T., Tang, B. Z., & Ning, S. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00511
Self-citationPlant-derived extracellular vesicles mimetic nano-system for synergistic sono-immunotherapy
Huang, Q., Luo, H., Qiu, J., Li, X., Zeng, W., & Zhu, D. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.124625
Self-citationLiu, W., Chen, Y., Xiao, Y., Gao, J., Hu, S., Chen, L., Song, J., & Yang, H. (2026) · Nano Letters · doi:10.1021/acs.nanolett.6c04189
Gong, J., Pan, X., Wang, S., Liu, Y., Wang, G., Yu, M., Ke, P. C., & Xu, M. (2026) · Discover Nano · doi:10.1186/s11671-026-05081-9
“…tumor microenvironments, synergistically inducing massive glioma cell apoptosis via ROS-triggered oxidative stress and heat necrosis dual pathways [33]; (2) minimal dark cytotoxicity without light stimulation, eliminating indiscriminate damage to normal host tissues; (3) in vitro hemolysis levels…”
Metadata
- Authors
- Xu, Q., Zhang, M., Huang, Q., Gao, S., Chu, S., Li, Q., Chen, W., Zhang, X., Zhang, T., Tang, B. Z., & Ning, S.
- Affiliations
- Harbin Medical University (CN)
- Liuzhou General Hospital (CN)
- Zhengzhou University (CN)
- Guangxi Medical University (CN)
- Guangzhou Medical University Cancer Hospital (CN)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Xu, Qingyong
- Zhang, Tianfu
- Tang, Ben Zhong
- Ning, Shipeng
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2025-06-19
- Volume
- 37
- Issue
- 35
- Pages
- e2502898-e2502898
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- PMC
- PMC12411993
- OpenAlex
- W4411434745
- Cited by
- 69
- References
- 67
- Citations by year
- 2026: 58 · 2025: 11
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Advanced Materials (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Natural Science Foundation of China (82303797, 82473348, 52303224)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515010855)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
- Keywords
- aggregation-induced emission, reactive oxygen species generation, ferriprotoporphyrin IX, hemin, NOX4, hydrogen peroxide, hydroxyl radicals, chemodynamic therapy, radioimmunotherapy, immunogenic cancer cell death, M2 macrophage polarization, tumor recurrence, memory T cells, antitumor immunity
- MeSH terms
- Animals, Glutathione, Hemin, Humans, Hydrogen Peroxide, Neoplasms, Radiation-Sensitizing Agents, X-Rays, Reactive Oxygen Species, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.